Bendopnea may signal radiation-induced lung injury after SBRT

A lung cancer patient developed breathlessness when bending forward after SBRT, alongside pneumonitis evolving into fibrosis despite low lung dose.

KEY POINTS

  • This case report describes a 69-year-old man with stage IA2 right upper lobe lung adenocarcinoma, a 30-pack-year smoking history, and mild COPD who underwent definitive SBRT rather than lobectomy because of substantial medical comorbidity. Baseline pulmonary function was relatively preserved, with FEV1 111% predicted and DLCO 68% predicted, and no significant pretreatment dyspnea.
  • Treatment consisted of 50 Gy in five nonconsecutive fractions over approximately 1.5 weeks, delivered with 6-MV flattening-filter-free VMAT using three noncoplanar partial arcs. Respiratory motion was managed with abdominal compression and 4D-CT-based ITV delineation, while daily CBCT verified positioning.
  • Treatment planning met institutional target and OAR criteria, with lung-minus-GTV V20 of 4.95% and mean lung dose of 3.47 Gy. Despite these relatively low lung doses, early ground-glass changes were already visible on treatment CBCT near the irradiated lesion, becoming more pronounced toward the fifth fraction.
  • Approximately 2–3 weeks after SBRT, the patient developed intermittent shortness of breath when bending forward, progressing to marked bendopnea, defined as breathlessness occurring within 30 seconds of bending at the waist. At the three-month review, he also reported exertional dyspnea and intermittent orthopnea, with resting oxygen saturation of 92%.
  • CT demonstrated treatment-related pulmonary changes consistent with radiation pneumonitis evolving toward fibrosis. Cardiac evaluation showed an NT-proBNP of 292 pg/mL, echocardiographic ejection fraction of 40–44%, and normal left ventricular end-diastolic pressure of 10 mmHg on cardiac catheterization; these findings argued against decompensated heart failure as the primary explanation but did not completely exclude a cardiac contribution.
  • The patient received prednisone with a short taper and antibiotics, with partial symptomatic improvement. At seven months, bendopnea and exertional dyspnea remained present but improved, while imaging demonstrated established post-radiation fibrosis; DLCO decreased from 68% to 60% predicted, with preserved FEV1 and no evidence of local tumor recurrence.
  • The authors proposed that radiation-related parenchymal stiffness and altered ventilation–perfusion relationships might contribute to dyspnea during forward bending, potentially exacerbated by COPD. This explanation remains speculative: one patient cannot establish a causal mechanism, and pre-existing cardiopulmonary disease may have contributed despite normal left ventricular filling pressures.

CLINICAL TAKEAWAY

New positional breathlessness after lung SBRT should prompt evaluation for radiation pneumonitis and fibrosis alongside conventional cardiac and pulmonary causes. Bendopnea may be an unusual presentation of radiation-related lung injury, but its diagnostic significance remains uncertain because the evidence is limited to a single case.

SOURCE

Advances in Radiation Oncology

Browse more research Suggest a correction